Skip to content

Global impact of ESC Guidelines

Thank you for taking part in this survey which will take approximately 12 minutes. Our goal is to assess the availability of interventions / products recommended in ESC guidelines. Every page of this survey represents a different category.

Before we continue, may we just remind you of our Code of Conduct for ESC surveys?
  • We comply with the European General Data Protection Regulation (GDPR) 2016/679. Any personal data processed in connection with this survey will be treated confidentially, will not be disclosed to any third party and will only be used by the ESC for the purposes of market research and not for promotion. Survey results will be kept for a maximum of 24 months for analysis and quality control purposes. We take all reasonable care to prevent any unauthorized access to your personal data. We respect your privacy and your right to access, modify, or remove your personal data. At any time, you can ask to know what personal data is being held. If you have any questions about data protection or require further information, please contact our data protection officer (DPO) at dpo@escardio.org.
  • You have the right to end your participation in this survey at any time.
1.Please confirm that you have read the above and agree to participate in this survey.
2.Please indicate your name(Required.)
3.What is your country of work?(Required.)
Pharmaceutical interventions / Vasoactive drugs & antihypertensives
4.Are the following treatments available in your country?
Please rate from 1 to 4, where:
  • 1=Not at all available in my country
  • 2=Mostly/often unavailable (in specific settings / areas / patients)
  • 3= Mostly/often available (in specific settings / areas / patients)
  • 4=Fully available (in most settings, regions and for most patients)


1
2
3
4
ACE inhibitors
ARBs
Dihydropyridine calcium channel blockers
Diuretics
Midodrine
Mineralocorticoid Receptor Antagonists
NTG iv
RAAS blockers
Pharmaceutical interventions / Rhythm controlling drugs & Antiarrhythmics
5.Are the following treatments available in your country?
Please rate from 1 to 4, where:
  • 1=Not at all available in my country
  • 2=Mostly/often unavailable (in specific settings / areas / patients)
  • 3= Mostly/often available (in specific settings / areas / patients)
  • 4=Fully available (in most settings, regions and for most patients)
1
2
3
4
Adenosine
Beta blockers
Cellprolol
Digoxin
Flecainide
Pharmaceutical interventions / Platelet inhibitors & anticoagulants
6.Are the following treatments available in your country?
Please rate from 1 to 4, where:
  • 1=Not at all available in my country
  • 2=Mostly/often unavailable (in specific settings / areas / patients)
  • 3= Mostly/often available (in specific settings / areas / patients)
  • 4=Fully available (in most settings, regions and for most patients)
1
2
3
4
Aspirin
Clopidogrel
P2Y12 inhibitors
Polypill
Prasugrel
LMWH
Thrombolytics
VKA
Pharmaceutical interventions / Lipid lowering drugs
7.Are the following treatments available in your country?
Please rate from 1 to 4, where:
  • 1=Not at all available in my country
  • 2=Mostly/often unavailable (in specific settings / areas / patients)
  • 3= Mostly/often available (in specific settings / areas / patients)
  • 4=Fully available (in most settings, regions and for most patients)
1
2
3
4
Cholesterol absorption inhibitor
Ezetimibe
Fibrates
PCSK9 inhibitors
Statins
Unfractionated heparin
Pharmaceutical interventions / Other drugs
8.Are the following treatments available in your country?
Please rate from 1 to 4, where:
  • 1=Not at all available in my country
  • 2=Mostly/often unavailable (in specific settings / areas / patients)
  • 3= Mostly/often available (in specific settings / areas / patients)
  • 4=Fully available (in most settings, regions and for most patients)
1
2
3
4
Corticosteroids
Epidural
Endothelial growth factor inhibitors
Ergometrine
Fludrocortisone
Insulin
Levodopa
Metformin
Oxytocin
SGLT2 inhibitors
Flu vaccinations
9.If applicable, for all the pharmaceutical products above which are not available (1) or only partially available (2 or 3), could you please indicate the top 3 reasons for that?
(please select 3 reasons maximum)
2 / 12
17%
Privacy & Cookie Notice